Dr Kiyoshi Nagai, a scientist at the U.K. Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, holds a phial of human haemoglobin intended as a blood substitute. The need to develop a blood substitute has arisen because of increasing concern over contamination of blood stocks with viral & bacterial pathogens, such as HIV, the virus causing AIDS. The products of earlier attempts using recombinant DNA techniques on the bacteria Escherichia coli & Saccharomyces cerevisiae had proved toxic to the kidneys. This latest version, developed by scientists at the MRC & Somatogen Inc. in the U.S., has overcome this problem.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP10192501
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: